Yuval Cohen

2016

In 2016, Yuval Cohen earned a total compensation of $2M as Chief Executive Officer at Corbus Pharmaceuticals Holdings, a 443% increase compared to previous year.

Compensation breakdown

Bonus$185,000
Option Awards$1,493,403
Salary$370,000
Total$2,048,403

Cohen received $1.5M in option awards, accounting for 73% of the total pay in 2016.

Cohen also received $185K in bonus and $370K in salary.

Rankings

In 2016, Yuval Cohen's compensation ranked 4,776th out of 14,075 executives tracked by ExecPay. In other words, Cohen earned more than 66.1% of executives.

ClassificationRankingPercentile
All
4,776
out of 14,075
66th
Division
Manufacturing
1,702
out of 5,486
69th
Major group
Chemicals And Allied Products
529
out of 1,900
72nd
Industry group
Drugs
390
out of 1,543
75th
Industry
Pharmaceutical Preparations
308
out of 1,173
74th
Source: SEC filing on April 10, 2017.

Cohen's colleagues

We found three more compensation records of executives who worked with Yuval Cohen at Corbus Pharmaceuticals Holdings in 2016.

2016

Barbara White

Corbus Pharmaceuticals Holdings

Chief Medical Officer

2016

Mark Tepper

Corbus Pharmaceuticals Holdings

Chief Scientific Officer

2016

Sean Moran

Corbus Pharmaceuticals Holdings

Chief Financial Officer

In-depth

You may also like